TuHURA Biosciences, Inc./NV (HURA) Operating cash flow 2016–2025
TuHURA Biosciences, Inc./NV (HURA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$27.6MFY2025 · since FY2016: -$5.1M → -$27.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.6M | -87.6% |
| FY2024 | -$14.7M | -23.2% |
| FY2023 | -$12.0M | +41.4% |
| FY2022 | -$20.4M | -8.1% |
| FY2021 | -$18.9M | -137.9% |
| FY2020 | -$7.9M | -25.3% |
| FY2019 | -$6.3M | +35.8% |
| FY2018 | -$9.9M | -22.8% |
| FY2017 | -$8.0M | -55.8% |
| FY2016 | -$5.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice